These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 7817919

  • 1. Natural antioxidants and restenosis after percutaneous transluminal coronary angioplasty.
    Godfried SL, Deckelbaum LI.
    Am Heart J; 1995 Jan; 129(1):203-10. PubMed ID: 7817919
    [No Abstract] [Full Text] [Related]

  • 2. Angioscopic prediction of successful dilatation and of restenosis in percutaneous transluminal coronary angioplasty. Significance of yellow plaque.
    Itoh A, Miyazaki S, Nonogi H, Daikoku S, Haze K.
    Circulation; 1995 Mar 01; 91(5):1389-96. PubMed ID: 7867178
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis.
    French BA, Mazur W, Ali NM, Geske RS, Finnigan JP, Rodgers GP, Roberts R, Raizner AE.
    Circulation; 1994 Nov 01; 90(5):2402-13. PubMed ID: 7955199
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty.
    Berk BC, Gordon JB, Alexander RW.
    J Am Coll Cardiol; 1991 May 01; 17(6 Suppl B):111B-117B. PubMed ID: 2016469
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty.
    Manegold C, Alwazzeh M, Jablonowski H, Adams O, Medve M, Seidlitz B, Heidland U, Häussinger D, Strauer BE, Heintzen MP.
    Circulation; 1999 Mar 16; 99(10):1290-4. PubMed ID: 10077511
    [Abstract] [Full Text] [Related]

  • 8. Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty.
    Macdonald RG, Panush RS, Pepine CJ.
    Am J Cardiol; 1987 Jul 31; 60(3):56B-60B. PubMed ID: 2956845
    [Abstract] [Full Text] [Related]

  • 9. Restenosis after coronary balloon angioplasty.
    Lange RA, Flores ED, Hillis LD.
    Annu Rev Med; 1991 Jul 31; 42():127-32. PubMed ID: 2035958
    [Abstract] [Full Text] [Related]

  • 10. Percutaneous coronary intervention in small coronary vessels: from balloon angioplasty to drug eluting stent era.
    Rathore S, Kaul U.
    Indian Heart J; 2011 Jul 31; 63(3):228-33. PubMed ID: 22734340
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty.
    Roguin A, Hochberg I, Nikolsky E, Markiewicz W, Meisel SR, Hir J, Grenadier E, Beyar R, Levy AP.
    Am J Cardiol; 2001 Feb 01; 87(3):330-2, A9. PubMed ID: 11165970
    [Abstract] [Full Text] [Related]

  • 13. Prevention of restenosis with antioxidants: mechanisms and implications.
    Tardif JC, Grégoire J, L'Allier PL.
    Am J Cardiovasc Drugs; 2002 Feb 01; 2(5):323-34. PubMed ID: 14727962
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Electron-beam computed tomographic detection of coronary calcification in patients undergoing percutaneous transluminal coronary angioplasty: predictability of restenosis. A preliminary report.
    Stanford W, Travis ME, Thompson BH, Reiners TJ, Hasson RR, Winniford MD.
    Am J Card Imaging; 1995 Oct 01; 9(4):257-60. PubMed ID: 8680142
    [Abstract] [Full Text] [Related]

  • 16. Value of exercise electrocardiography in the detection of restenosis after coronary angioplasty in patients with one-vessel disease.
    Malekianpour M, Rodés J, Côté G, Juneau M, Bonan R, Lespérance J, Couturier A, Tardif JC.
    Am J Cardiol; 1999 Aug 01; 84(3):258-63. PubMed ID: 10496432
    [Abstract] [Full Text] [Related]

  • 17. [Percutaneous transluminal laser coronary angioplasty (PTLCA)].
    Yamasawa I.
    Nihon Rinsho; 1994 Jul 01; 52 Suppl(Pt 1):906-10. PubMed ID: 12436636
    [No Abstract] [Full Text] [Related]

  • 18. Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty.
    Carlsson J, Miketic S, Mueller KH, Brom J, Ross R, von Essen R, Tebbe U.
    Lancet; 1997 Oct 25; 350(9086):1225. PubMed ID: 9652570
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.